In this article
The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly
’s rival pill that was approved this week, Novo Nordisk
said Thursday.
Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under the brand name Foundayo from next week, in an indirect study that compared the outcomes of other studies.
